Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Monoclonal Antibodies in Treatment of Multiple Sclerosis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Hepatocyte Growth Factor Limits Autoimmune Neuroinflammation via Glucocorticoid-Induced Leucine Zipper Expression in Dendritic Cells.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells' attachment and differentiation.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Accurately diagnosing and comprehensively managing MS.
Evaluation of hemodynamic properties of cerebral venous drainage in patients with multiple sclerosis: a case-control study.
Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
How does magnetization transfer influence mcDESPOT results?
Pages
« first
‹ previous
…
325
326
327
328
329
330
331
332
333
…
next ›
last »